Nonfatal ED visits for substance use (California, 2014)

nonfatal_ED_visits2012-2014Nonfatal ED visits for alcohol or other drug diagnoses
California, annual average, 2012-2014
2018 Edition — Substance Use in California
A look at addiction and treatment
October 3, 2018
Wendy Holt, DMA Health Strategies




Dr. Robert Lefever

Why some of us are addicts | Robert Lefever

Everyday Addiction Interventions: Loving and Relentless | Susan Riegler |

There needs to be the choice that one wants to stop

Addiction: When You Fear It’s Just A Matter Of Time
November 1, 2011

Dr. Schneekloth: You know, well, ultimately there needs to be the choice that one wants to stop. But that’s often when the pressure increases to a point that there seem no alternatives.

…, but ultimately the decision needs to be made by the one with the addiction: Are they going to stop?

Now, some people can stop on their own. As a matter of fact, the majority of alcoholics stop, never receive addiction treatment, go on to do well. There are different types, though, and some have more severe forms of addiction and need multiple treatments.

… there are repeated exacerbations of the illness, that it comes back. And in the same way with addiction, relapse is often a part of it. Now, families can feel like that’s somehow a failure, but often one treatment builds on another and eventually leads, like Nicolas’ story, to ongoing recovery.

The Real Wealth is Health

Hooked, Hacked, Hijacked: Reclaim Your Brain from Addictive Living
Dr. Pam Peeke at TEDxWallStreet
Nov 26, 2013

Dr. Pamela Peeke is an internationally renowned physician, scientist and exper t in the fields of nutrition, metabolism, stress and fitness. Triathlete and marathoner, Dr. Peeke is nationally known as the “doc who walks the talk” inspiring through example. Dr. Peeke is the lifestyle exper t for WebMD’s 90 million members, and a regular blogger on cutting edge science in health and wellness. Presently, Dr. Peeke is Senior Science Advisor to Elements Behavioral Health, the nation’s most preeminent network of eating disorders and addiction centers. Her current research focuses on how addictive behaviors have subtly and often profoundly penetrated daily lifestyle habits.


Dopamine Receptor Agonist Drugs and Impulse Control Disorders

Dopamine Receptor Agonist Drugs and Impulse Control Disorders
JAMA Intern Med. October 20, 2014

The discovery of striatal dopamine deficiency and the introduction of levodopa in the 1960s as treatment for the motor symptoms of Parkinson disease revolutionized neurology and neurotherapeutics.
For the first time, patients with an apparently hopeless chronic degenerative brain disorder were able to regain function and return to the mainstream of life.
Levodopa was subsequently combined with carbidopa, as the latter prevented the adverse effects associated with peripheral dopamine synthesis without blocking central dopamine synthesis.

journalistic version:

How Do We Predict the Future …

How Do We Predict the Future: Brains Rewards and Addiction  
Terry Sejnowski
The Salk Institute
Series: “Grey Matters” [6/2005]
University of California Television (UCTV)

how by its nature the human brain is susceptible to the effects of addictive substances.

cited by:
Learning How to Learn
by University of California, San Diego
on Coursera.